NEVVI Medicare utilization intelligence
or

← back

Provider profile

ELBOGDADI, DANIEL MD

Rheumatology · NPI 1528186285 · FAIRFAX, VA

1
Groups
64
Codes · 2024
85,079
Disclosed services

ELBOGDADI, DANIEL is a Rheumatology in FAIRFAX, VA, a member of 1 medical group, who billed 64 distinct codes to Medicare Part B in 2024.

Groups: ARTHRITIS AND RHEUMATISM ASSOCIATES PC (ROCKVILLE, MD)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

85,079
disclosed services
64
codes billed to Medicare Part B
Prior year · CY2023 75,567 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J3262 Injection, tocilizumab, 1 mg
J3111 Injection, romosozumab-aqqg, 1 mg
J0897 Injection, denosumab, 1 mg
J1602 Injection, golimumab, 1 mg, for intravenous use
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
J1010 Injection, methylprednisolone acetate, 1 mg
J1745 Injection, infliximab, excludes biosimilar, 10 mg
J7320 Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
80053 Blood test, comprehensive group of blood chemicals
36415 Insertion of needle into vein for collection of blood sample
86140 Measurement c-reactive protein for detection of infection or inflammation
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
85652 Red blood cell sedimentation rate, to detect inflammation, automated
86235 Measurement of antibody for assessment of autoimmune disorder, any method
96372 Injection of drug or substance under skin or into muscle
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96413 Administration of chemotherapy into vein, 1 hour or less
77080 Dxa bone density measurement of hip, pelvis, spine
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
86160 Measurement of complement (immune system proteins), antigen,
86255 Screening test for antibody to noninfectious agent
97112 Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes
97530 Therapy procedure using functional activities
82306 Vitamin d-3 level
84550 Uric acid level, blood
J3489 Injection, zoledronic acid, 1 mg
86200 Measurement of antibody for rheumatoid arthritis assessment
86431 Rheumatoid factor level
76881 Complete ultrasound scan of joint
97140 Therapy procedure using manual technique, each 15 minutes
97110 Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes
82550 Creatine kinase (cardiac enzyme) level, total
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
73562 X-ray of knee, 3 views
20610 Aspiration and/or injection of fluid from large joint
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
73130 X-ray of hand, minimum of 3 views
84443 Blood test, thyroid stimulating hormone (tsh)
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
20611 Aspiration and/or injection of fluid large joint using ultrasound guidance
73110 X-ray of wrist, minimum of 3 views
81001 Manual urinalysis test with examination using microscope, automated
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
72170 X-ray of pelvis, 1-2 views
73630 X-ray of foot, minimum of 3 views
76942 Ultrasonic guidance for needle placement
80061 Blood test, lipids (cholesterol and triglycerides)
82310 Calcium level, total
97162 Evaluation for physical therapy, typically 30 minutes
20550 Injection into tendon or ligament
72110 X-ray of lower and sacral spine, minimum of 4 views
82570 Creatinine level to test for kidney function or muscle injury
84156 Total protein level, urine
84439 Thyroxine (thyroid chemical), free
99442 Telephone medical discussion with physician, 11-20 minutes
J1030 Injection, methylprednisolone acetate, 40 mg
87081 Screening test for pathogenic organisms
89051 Body fluid cell count with cell identification
89060 Crystal identification from tissue or body fluid
20600 Aspiration and/or injection of fluid from small joint
72070 X-ray of middle spine, 2 views

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.